Free tool
FAERS Monitor: Amicar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 015230 or its brand name (Amicar, Aminocaproic Acid). Reports on generic versions are filed under their own applications.
Reports
801
Serious
606
76% of reports
Hospitalization
304
Death reported
144
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- haemorrhage144
- off label use67
- epistaxis61
- drug ineffective52
- fall40
- death37
- mouth haemorrhage37
- haemarthrosis36
- hypotension30
- contusion29
- pain29
- thrombocytopenia27
- pyrexia26
- head injury22
- anaemia20
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 12 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 19 |
| 2010 | 17 |
| 2011 | 34 |
| 2012 | 12 |
| 2013 | 17 |
| 2014 | 18 |
| 2015 | 28 |
| 2016 | 24 |
| 2017 | 16 |
| 2018 | 17 |
| 2019 | 49 |
| 2020 | 45 |
| 2021 | 43 |
| 2022 | 37 |
| 2023 | 78 |
| 2024 | 105 |
| 2025 | 113 |
| 2026 | 98 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,358 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| mouth haemorrhageSignal | 37 | 133.2 | 97.1 | 4,701 |
| haemarthrosisSignal | 36 | 105.9 | 76.9 | 3,624 |
| haemorrhageSignal | 144 | 36.2 | 31.2 | 4,914 |
| epistaxisSignal | 61 | 21.4 | 16.8 | 1,171 |
| head injurySignal | 22 | 18.3 | 12.1 | 342 |
| contusionSignal | 29 | 7.9 | 5.5 | 169 |
| thrombocytopeniaSignal | 27 | 6.3 | 4.4 | 117 |
| hypotensionSignal | 30 | 3.9 | 2.8 | 63 |
| fallSignal | 40 | 3.2 | 2.3 | 58 |
| anaemiaSignal | 20 | 2.8 | 1.8 | 21 |
| off label useSignal | 67 | 2.0 | 1.6 | 34 |
| pyrexia | 26 | 2.0 | 1.4 | 12 |
| pain | 29 | 1.2 | 0.9 | 1 |
| death | 37 | 1.1 | 0.8 | 0 |
| drug ineffective | 52 | 1.0 | 0.8 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.